Table 3:
First-Line Antiretroviral Therapy Regimens Prescribed to HIV-infected Children in Mozambique during 2004–2009
| ≤ 3 years old | > 3 years old | Overall | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | N | % | 95% CI | n | N | % | 95% CI | n | N | % | 95% CI | |
| D4T-3TC-NVP | 148 | 450 | 38% | (27–49%) | 423 | 514 | 83% | (76–89%) | 571 | 964 | 61% | (55–68%) |
| D4T-3TC-EFV | 6 | 450 | 1% | (0–2%) | 35 | 514 | 7% | (3–11%) | 41 | 964 | 4% | (2–6%) |
| D4T-3TC-LPV/r | 3 | 450 | 0% | (0–1%) | 0 | 514 | 0% | (0–0%) | 3 | 964 | 0% | (0–1%) |
| AZT-3TC-ABC | 20 | 450 | 4% | (2–7%) | 2 | 514 | 0% | (0–1%) | 22 | 964 | 2% | (1–3%) |
| AZT-3TC-NVP | 268 | 450 | 55% | (44–66%) | 40 | 514 | 8% | (4–11%) | 308 | 964 | 30% | (24–37%) |
| AZT-3TC-EFV | 1 | 450 | 0% | (0–1%) | 10 | 514 | 2% | (0–4%) | 11 | 964 | 1% | (0–2%) |
| D4T-3TC-ABC | 2 | 450 | 0% | (0–1%) | 4 | 514 | 1% | (0–1%) | 6 | 964 | 1% | (0–1%) |
| D4T-3TC-other | 1 | 450 | 0% | (0–1%) | 0 | 514 | 0% | (0–0%) | 1 | 964 | 0% | (0–0%) |
| D4T-AZT-NVP | 1 | 450 | 0% | (0–1%) | 0 | 514 | 0% | (0–0%) | 1 | 964 | 0% | (0–0%) |
| missing | 45 | 495 | 9% | 45 | 559 | 8% | 90 | 1054 | 9% | |||
Abbreviations: CI, confidence interval; D4T, stavudine; AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; EFV, efavirenz; ABC, abacavir; LPV/r, lopinavir-ritonavir.